Limited and External Funding Opportunity Announcements

General guidelines for Limited Submissions


Active Internal Calls for Limited Submission Nominations 


American Diabetes Association - Pathway to Stop Diabetes program

Internal Submissions due April 28th

Vanderbilt University Medical Center may nominate one candidate for the 2017 American Diabetes Association Pathway to Stop Diabetes awards competition. The nominee may apply for one of the following:

 

Initiator Award

  • Award Type: Researchers in training transitioning to independence
  • Support: Up to $1.625M total over two phases
  • Term:
    • ​​Phase 1 (mentored)
      • $100,000/year maximum
      • 2 years
    • Phase 2 (independent)
      • $325,000/year maximum
      • 5 years

Accelerator Award

  • Award Type: Early-career diabetes investigators
  • Support: Up to $1.625M total; $325,000/year
  • Term: 5 years

Visionary Award

  • Award Type: Established investigators new to diabetes
  • Support: Up to $1.625M total; $325,000/year
  • Term: 5 years

Anyone interested in being considered as VUMC’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu  by 5 p.m. on April 28, 2017

  • Brief (2 page maximum) research plan including summary budget;
  • Brief statement of support from department chair/center director;
  • A CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email.  All applicants should verify their eligibility in advance through the sponsor website. Please review all requirements of the grant and discuss with the appropriate department chair/center director before submitting.

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a full proposal to the Foundation by the July 3, 2017 deadline.

If you have any questions about the sponsor or its interests and priorities, please contact Megan Smallwood, (57529), Program Manager in the Office of Research.


V Foundation BRCA 1,2 Research Collaborative Grants

Internal Submissions due May 28th

Vanderbilt University Medical Center (VUMC) has been invited to participate in a brand new opportunity – The V Foundation BRCA 1,2 Research Collaborative Grants. 

VUMC may one candidate for each of the following two categories:

Convergence Team Award: To support research projects that leverage novel collaborations between biomedical scientists and other researchers that might be brought into the field to work together across disciplines to drive our understanding and treatment of BRCA 1,2 related cancers. Each team must include experts in multiple disciplines to create a research plan and drive BRCA 1/-2 cancer research into new and innovative areas. The research may be basic, translational, clinical, or epidemiological in nature. We encourage collaborations within and between research institutions. If the award is made to a collaborative team across multiple institutions, the grant will be made to the institution that nominated the lead PI and that lead institution will manage any sub-contracts with collaborating institutions. The Convergence Team Award is a $2,100,000 grant, paid in increments of $700,000 for each of three years. 

Translational Award: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 5 years. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial. The Translational Award is a three-year grant of $200,000 per year.

Applicant Eligibility:  

All nominated applicants must meet all of the following criteria to be eligible to submit an application:

  • Applicant must be employed at a US non-profit research institution (e.g. 501c3, Section 170).
  • By the Due Date of the Application, applicants who will lead this research team must have all the following:
    • Be scientists who hold a faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team. Applicants must be either US Citizens or have a legal permit to work in the USA (either temporary or permanent).

Anyone interested in being considered as either of VUMC’s nominees must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on Friday, May 26, 2017.

  • Brief (2 page maximum) research plan including summary budget;
  • Brief statement of support from department chair/center director;
  • CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email. 

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a full proposal to the Foundation by the July 2017 deadline.

If you have any questions about the Foundation or its interests and priorities, please contact Megan Smallwood, Program Manager in the Office of Research.


Active Internal Calls for NON-Limited External Nominations 

Ovarian Cancer Research Fund Alliance (OCRFA) Grant Awards

LOIs due April 28th

Ann Schreiber Mentored Investigator Award

Ovarian Cancer Research Fund Alliance is requesting Letters of Intent for the 2018 Ann and Sol Schreiber Mentored Investigator Award.  This grant provides funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research, or relevant area.  

Eligibility and Selection Criteria
1. Applicants must be either clinical fellows (Gynecologic Oncology, Medical Oncology) or postdoctoral fellows. Candidates for this grant must have an M.D. or Ph.D. degree.
2. Applicants must be working in institutions with well-developed ovarian cancer research programs, in a school of medicine or public health, or a recognized non-profit scientific research facility in the United States.
3. Applicants should be involved in either laboratory, clinical, or epidemiology research. The research leader who will serve as the mentor should have significant independent cancer research funding (NCI, DOD, OCRF, etc.).
4. PhD applicants must be no more than 5 years out of their terminal degree at time of application (e.g. terminal degree must have been awarded during 2012 or later); MDs must currently enrolled in a fellowship program.
5. The selection committee will consider the strength of the research environment and project proposal, the trainee’s prior academic track record, and the likelihood of his/her pursuing a research career dedicated to ovarian cancer. The research plan proposed should have sufficient scientific depth to potentially lead to publication of results in high quality journals. Ideally, the project proposed should be one that the trainee’s mentor believes will advance the overall scientific objectives of the research group.

Collaborative Research Development Grant

Ovarian Cancer Research Fund Alliance is requesting Letters of Intent for the 2018 Collaborative Research Development Grant (formerly called the Program Project Development Grant). The purpose of this grantmaking program is to provide funds for ovarian cancer research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged.

Eligibility and Selection Criteria
1. The Principal Investigator (one Principal Investigator must be selected) and other investigators must have full-time faculty appointments in a school of medicine or public health or recognized non-profit scientific research facility in the United States. They should not currently be in a training program.
2. The selection committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics.
3. The primary review criteria will be the likelihood that the investigators can leverage this funding to establish a research team capable of performing high-impact research and competing successfully for additional funding.

Liz Tilberis Early Career Award

Ovarian Cancer Research Fund Alliance is requesting Letters of Intent for the 2018 Liz Tilberis Early Career Award. The Liz Tilberis Early Career Award is for junior faculty with a strong commitment to an investigative career in the field of ovarian cancer research. The intent of these awards is to support a substantial time commitment to research and academic endeavors in ovarian cancer.

Eligibility and Selection Criteria

1. Applicants must be working in institutions with strong existing ovarian cancer research programs, in a school of medicine or public health, or a recognized non-profit scientific research facility in the United States.
2. Applicants should have strong training in preparation for an investigative career in ovarian cancer research and prior academic accomplishments.
3. The selection committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of early detection, prevention, treatment, and translational ovarian cancer research. The proposed research plan should have sufficient scientific depth to allow the Liz Tilberis grantee to compete for additional funding after the period of this award.
4. Candidates must have an M.D. or Ph.D. degree and should be in the first five years of their first academic appointment after having completed their fellowship or postdoctoral training (Assistant Professor or equivalent). Individuals who will begin such a position by July 2017 are eligible for this award. Liz Tilberis awards will not be granted to individuals who hold similar junior investigator awards from other funding agencies or foundations.
5. If invited to submit a full proposal, applicants will be required to provide two letters of recommendation, including one from someone in a position to mentor the applicant.


The Franklin Institute Bower Award and Prize for Achievement in Science

Applications due May 31, 2017

Theme: Genome Editing

Prize: $250,000 

The Franklin Institute seeks nominations for the 2018 Bower Award and Prize for Achievement in Science of individuals who have made significant contributions to our understanding or the development of genome editing and/or its applications. Nominations may recognize contributions including, but not limited to, the discovery/elucidation of genome editing mechanisms such as those involving CRISPR, TALENs, or zinc finger nucleases; genome editing tool development; or genome editing for basic research or applied outcomes in a variety of systems (e.g. for crop improvement or medical therapeutics). Nominations must clearly indicate the scientific impact of the nominee’s work, whether conceptual, technical, or integrative.

Eligibility:

  • This is an international competition for individuals who have made significant contributions to our understanding or the development of genome editing and/or its applications.
  • This award and prize must be presented to an individual, as specified by the will of Henry Bower.
  • Candidates must be living, and the winner must participate in The Franklin Institute Awards Week programs, to be held in April 2018 in Philadelphia, Pennsylvania, USA.
  • Self-nominations are accepted.

Please visit the website for application details and instructions for submission.


Eppendorf & Science Prize for Neurobiology

Applications due June 15, 2017

The Prize is awarded annually to one young scientist for the most outstanding neurobiological research based on methods of molecular and cell biology conducted by him/her during the past three years.

Prize money: $25,000

Rules of Eligibility

  • Entrants must be a neurobiologist with an advanced degree received in the last 10 years and not older than 35 years of age.
  • The entrant's essay must describe contributions to neurobiological research based on methods of molecular and cell biology.
  • The entrant must have performed or directed the work described in the essay.
  • The research must have been performed during the previous three years.

Please visit the website for application details and instructions for submission.


Merck Investigator Studies Program (MISP)

LOIs reviewed on an ongoing basis. There are no deadlines.

Amount: The amount is not specified. Financial and/or product support is contingent upon full execution by both parties of the research agreement.

Applicant Type: Graduate Student, New Faculty/New Investigator, Ph.D./M.D./Other Professional

Abstract: The Mission Statement is to advance science and improve patient care by supporting, through the provision of drug/vaccine and/or total/partial funding, high-quality research that is initiated, designed, implemented and sponsored by external investigators. Results will be generated and properly disseminated in peer-reviewed publications.

This program consists of committees of medical and scientific staff from different therapeutic areas who meet regularly to review Merck investigator study proposals. Support is provided based on the scientific merit of the proposal as well as whether it is in alignment with the published areas of interest. Information related to areas of interest and requirements for submission can be found by clicking on the appropriate link for your therapeutic area.

The current MISP areas supported are:

  • Cardiovascular
  • Endocrinology
  • Health Literacy/Diversity/Adherence
  • Infectious Disease
  • Merck for Mothers
  • Neuroscience
  • Oncology
  • Respiratory/Allergy
  • Surgery
  • Women's Health
  • Vaccines

Eligibility: The Merck Investigator Studies Program is open to all academic and community-based physicians and researchers worldwide who are interested in conducting their own research.


Walmart Foundation National Giving Program

LOIs reviewed on an ongoing basis. There are no deadlines.

The underlying focus in all of the Walmart Foundation's work is on empowering low-income people to help them live better. This program allows the Foundation to work strategically with organizations working across one or more states to address social issues strongly aligned with the Foundation's focus areas. 

The program awards grants of $250,000 and above. Overhead/indirect costs (i.e., non-program-related expenses) may not exceed 10% of the total program budget. Walmart and the Walmart Foundation do not currently award multi-year commitments. Organizations may, however, propose initiatives with timeframes that extend up to two years. No-cost extensions may be requested for up to an additional 12 months, if necessary. 

Please visit the website for application details and instructions for submission.